Treatment with selumetinib preserves cardiac function and improves survival in cardiomyopathy caused by mutation in the lamin A/C gene.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cardiovascular Research

• Publication date

  2012-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/cvr/cvr301PMID 22068161
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice

  2011cited by this paper
• Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers.

  2011cited by this paper
• Phase II study of the mitogen-activated protein kinase 1/2 inhibitor selumetinib in patients with advanced hepatocellular carcinoma.

  2011cited by this paper
• Mitogen-Activated Protein Kinase Inhibitors Improve Heart Function and Prevent Fibrosis in Cardiomyopathy Caused by Mutation in Lamin A/C Gene

  2011cited by this paper
• MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation.

  2011cited by this paper
• Long-term safety of sorafenib in advanced renal cell carcinoma: follow-up of patients from phase III TARGET.

  2010cited by this paper
• Improvement of left ventricular dysfunction and of survival prognosis of dilated cardiomyopathy by administration of calcium sensitizer SCH00013 in a mouse model.

  2010cited by this paper
• From basic research to clinical development of MEK1/2 inhibitors for cancer therapy

  2010cited by this paper
• Pharmacological inhibition of c-Jun N-terminal kinase signaling prevents cardiomyopathy caused by mutation in LMNA gene.

  2010cited by this paper
• The Novel 2nd Generation Small Molecule MEK Inhibitor, AZD-6244, Induces Cell Death in Lymphoma Cells Lines, Primary Cells, and in a Human Lymphoma Xenograft Model.

  2009cited by this paper
• Laminopathies and the long strange trip from basic cell biology to therapy.

  2009cited by this paper
• Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy.

  2008cited by this paper
• Long-term outcome and risk stratification in dilated cardiolaminopathies.

  2008cited by this paper
• Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics

  2008cited by this paper
• Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers.

  2008cited by this paper
• Inhibition of extracellular signal-regulated kinase signaling to prevent cardiomyopathy caused by mutation in the gene encoding A-type lamins.

  2008cited by this paper
• Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy.

  2007cited by this paper
• Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor

  2007cited by this paper
• Mouse models of the laminopathies.

  2007cited by this paper
• Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies.

  2005cited by this paper
• Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death?

  2004cited by this paper
• Real-time PCR based on SYBR-Green I fluorescence: An alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions

  2003cited by this paper
• BMC Biotechnology BioMed Central Methodology article Quantitative Real Time Polymerase Chain Reaction for

  2003cited by this paper
• Natural history of dilated cardiomyopathy due to lamin A/C gene mutations.

  2003cited by this paper
• Caveolin-3 Knock-out Mice Develop a Progressive Cardiomyopathy and Show Hyperactivation of the p42/44 MAPK Cascade*

  2002cited by this paper
• Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease.

  2002cited by this paper
• Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure

  2001cited by this paper
• Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).

  2000cited by this paper
• Trypanosoma cruzi infection (Chagas' disease) of mice causes activation of the mitogen-activated protein kinase cascade and expression of endothelin-1 in the myocardium.

  2000cited by this paper
• Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy

  1999cited by this paper
• Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease.

  1999cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias.

  2026cites this paper
• Role of Nuclear Envelope Proteins in the Structure and Function of the Neuromuscular Junction: Focus on Subsynaptic Nuclei.

  2025cites this paper
• LMNA-related cardiomyopathy: From molecular pathology to cardiac gene therapy

  2025cites this paper
• Perinuclear organelle trauma at the nexus of cardiomyopathy pathogenesis arising from loss of function LMNA mutation

  2025cites this paper
• From gene to mechanics: a comprehensive insight into the mechanobiology of LMNA mutations in cardiomyopathy

  2024cites this paper
• Unraveling the nexus of nesprin in dilated cardiomyopathy: From molecular insights to therapeutic prospects.

  2024cites this paper
• Modulation of cytoskeleton in cardiomyopathy caused by mutation in LMNA gene.

  2023cites this paper
• Emerin deficiency does not exacerbate cardiomyopathy in a murine model of Emery–Dreifuss muscular dystrophy caused by an LMNA gene mutation

  2023cites this paper
• Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias.

  2023cites this paper
• Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X

  2023cites this paper
• Effective use of genetically-encoded optical biosensors for profiling signalling signatures in iPSC-CMs derived from idiopathic dilated cardiomyopathy patients

  2022cites this paper
• Skeletal and Cardiac Muscle Disorders Caused by Mutations in Genes Encoding Intermediate Filament Proteins

  2021cites this paper
• Phenotypic Variability in iPSC-Induced Cardiomyocytes and Cardiac Fibroblasts Carrying Diverse LMNA Mutations

  2021cites this paper
• Preclinical Advances of Therapies for Laminopathies

  2021cites this paper
• Molecular Pathology of Laminopathies.

  2021cites this paper
• A CRISPR/Cas9 zebrafish lamin A/C mutant model of muscular laminopathy

  2021cites this paper
• THE NUCLEUS: mechanosensing in cardiac disease.

  2021cites this paper
• Epigenetics in cardiac development and human induced pluripotent stem cells

  2021cites this paper
• Tumor necrosis factor‐α promotes and exacerbates calcification in heart valve myofibroblast populations

  2021cites this paper
• RNA Sequence Analyses throughout the Course of Mouse Cardiac Laminopathy Identify Differentially Expressed Genes for Cell Cycle Control and Mitochondrial Function

  2020cites this paper
• Protein Kinase C Alpha Cellular Distribution, Activity, and Proximity with Lamin A/C in Striated Muscle Laminopathies

  2020cites this paper
• A lamin A/C variant causing striated muscle disease provides insights into filament organization

  2020cites this paper
• Emerging roles of lamins and DNA damage repair mechanisms in ovarian cancer.

  2020cites this paper
• Gene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis

  2020cites this paper
• SOS1 Gain-of-Function Variants in Dilated Cardiomyopathy

  2020cites this paper
• Genotype‐phenotype analysis of LMNA‐related diseases predicts phenotype‐selective alterations in lamin phosphorylation

  2020cites this paper
• Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53.

  2020cites this paper
• Ablation of SUN2-containing LINC complexes drives cardiac hypertrophy without interstitial fibrosis

  2019cites this paper
• TAK733 attenuates adrenergic receptor-mediated cardiomyocyte hypertrophy via inhibiting ErkThr188 phosphorylation

  2019cites this paper
• Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onset.

  2019cites this paper
• The Cutting Edge: The Role of mTOR Signaling in Laminopathies

  2019cites this paper
• Cellular and Animal Models of Striated Muscle Laminopathies

  2019cites this paper
• Postnatal Development of Mice with Combined Genetic Depletions of Lamin A/C, Emerin and Lamina-associated Polypeptide 1.

  2019cites this paper
• Deficiency of emerin contributes differently to the pathogenesis of skeletal and cardiac muscles in LmnaH222P/H222P mutant mice

  2019cites this paper
• Lamin A/C Cardiomyopathy: Implications for Treatment

  2019cites this paper
• ERK1/2 Phosphorylation of FHOD Connects Signaling and Nuclear Positioning Alternations in Cardiac Laminopathy.

  2019cites this paper
• Intermediate filaments in cardiomyopathy

  2018cites this paper
• Role of Lamin A/C Gene Mutations in the Signaling Defects Leading to Cardiomyopathies

  2018cites this paper
• The Pathogenesis and Therapies of Striated Muscle Laminopathies

  2018cites this paper
• Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease.

  2018cites this paper
• Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival

  2018cites this paper
• Mechanotransduction, nuclear architecture and epigenetics in Emery Dreifuss Muscular Dystrophy: tous pour un, un pour tous

  2018cites this paper
• Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutation

  2018cites this paper
• Cell signaling abnormalities in cardiomyopathy caused by lamin A/C gene mutations.

  2017cites this paper
• MAPK signaling pathways and HDAC3 activity are disrupted during differentiation of emerin-null myogenic progenitor cells

  2017cites this paper
• Lamin A/C Cardiomyopathies: Current Understanding and Novel Treatment Strategies

  2017cites this paper
• Decreased WNT/&bgr;-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene

  2017cites this paper
• Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.

  2017cites this paper
• Cardiomyopathy Caused by Mutations in Nuclear A-Type Lamin Gene

  2017cites this paper
• Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies

  2017cites this paper
• Current insights into LMNA cardiomyopathies: Existing models and missing LINCs

  2017cites this paper
• Diseases of the Nuclear Membrane

  2017cites this paper
• Lamins in Inherited Disease

  2017cites this paper
• Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects

  2017cites this paper
• Clinical features and therapeutic strategies for managing the striated muscle laminopathies

  2016cites this paper
• High-Throughput Screening for Drugs that Modulate Intermediate Filament Proteins.

  2016cites this paper
• ERK1/2 directly acts on CTGF/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A/C gene.

  2016cites this paper
• Targeting Mitogen-Activated Protein Kinase Signaling in Mouse Models of Cardiomyopathy Caused by Lamin A/C Gene Mutations.

  2016cites this paper
• Roles of ERK1/2 signaling in LMNA-cardiomyopathy

  2016cites this paper
• Causes and consequences of nuclear envelope alterations in tumour progression.

  2016cites this paper
• Selumetinib, an Oral Anti-Neoplastic Drug, May Attenuate Cardiac Hypertrophy via Targeting the ERK Pathway

  2016influential citation
• PKC412 normalizes mutation‐related keratin filament disruption and hepatic injury in mice by promoting keratin–myosin binding

  2015cites this paper
• Cardiac Cytoarchitecture

  2015cites this paper
• The Nuclear Envelope in Cardiac Health and Disease

  2015cites this paper
• Atteintes ventriculaires droites liées aux laminopathies : prévalence et pronostic dans une cohorte de 138 patients

  2015cites this paper
• Risk of Selected Cardiovascular Toxicities in Patients With Cancer Treated With MEK Inhibitors: A Comparative Systematic Review and Meta-Analysis

  2015cites this paper
• Nuclear envelope and striated muscle diseases.

  2015cites this paper
• Nuclear envelope regulation of signaling cascades.

  2014cites this paper
• On the role of prelamin A in the heart

  2014cites this paper
• Cellular mechanosensing: getting to the nucleus of it all.

  2014cites this paper
• Depletion of lamina-associated polypeptide 1 from cardiomyocytes causes cardiac dysfunction in mice

  2014cites this paper
• Striated muscle laminopathies.

  2014cites this paper
• Forte incidence à la Réunion d'une mutation homozygote de la lamine responsable d'un phénotype lipodystrophique (Dunnigan) à haut risque d'arythmie ventriculaire maligne : étude rétrospective d'une cohorte de 40 patients

  2014influential citation
• Mitogen-activated protein kinase kinase 1/2 inhibition and angiotensin II converting inhibition in mice with cardiomyopathy caused by lamin A/C gene mutation.

  2014cites this paper
• STUDIO DELLE CITOCHINE NELLA DISTROFIA MUSCOLARE DI EMERY-DREIFUSS: POSSIBILI MARKER PATOGENETICI E BERSAGLI DI CURA DELLA MALATTIA

  2014cites this paper
• Post-translational modifications of intermediate filament proteins: mechanisms and functions

  2014cites this paper
• Depletion of extracellular signal-regulated kinase 1 in mice with cardiomyopathy caused by lamin A/C gene mutation partially prevents pathology before isoenzyme activation.

  2014cites this paper
• The cellular mastermind(?)-mechanotransduction and the nucleus.

  2014cites this paper
• Role of nuclear Lamin A/C in cardiomyocyte functions

  2014influential citation
• Extracellular signal-Regulated Kinases 1/2 and their role in cardiac diseases

  2014cites this paper
• The Nuclear Envelope: An Intriguing Focal Point for Neurogenetic Disease

  2014cites this paper
• Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations

  2013cites this paper
• ‘State-of-the-heart’ of cardiac laminopathies

  2013cites this paper
• LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies

  2013cites this paper
• Novel insights into the disease etiology of laminopathies

  2013cites this paper
• Lamina-associated polypeptide-1 interacts with the muscular dystrophy protein emerin and is essential for skeletal muscle maintenance.

  2013cites this paper
• Noninvasive imaging of myocardial extracellular matrix for assessment of fibrosis

  2013cites this paper
• Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation

  2013cites this paper
• What Should the Cardiologist know about Lamin Disease?

  2012cites this paper
• Understanding the Roles of Nuclear A- and B-type Lamins in Brain Development*

  2012cites this paper
• [Clinical and genetic aspects of hypertrophic and dilated cardiomyopathy].

  2012cites this paper
• Abnormal p38α mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A/C gene mutation.

  2012cites this paper
• Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy Caused by Lamin A/C Gene Mutation

  2012influential citation
• Klinik und Genetik der hypertrophen und dilatativen Kardiomyopathie

  2012cites this paper
• Muscle development, regeneration and laminopathies: how lamins or lamina-associated proteins can contribute to muscle development, regeneration and disease

  2012cites this paper
• Dual Specificity Phosphatase 4 Mediates Cardiomyopathy Caused by Lamin A/C (LMNA) Gene Mutation*

  2012cites this paper
• Modeling of lamin A/C mutation premature cardiac aging using patient-specific induced pluripotent stem cells

  2012cites this paper
• Nuclear lamins and brain development*

  2012cites this paper
• Caused by Lamin A / C Gene Mutation Temsirolimus Activates Autophagy and Ameliorates Cardiomyopathy

  2012cites this paper